Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2025-12-31 @ 4:00 PM
Study NCT ID:
NCT00449033
Status:
COMPLETED
Last Update Posted:
2015-04-23
First Post:
2007-03-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02
Start Date Type:
None
Primary Completion Date:
2010-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-16
First Submit QC Date:
None
Study First Post Date:
2007-03-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-20
Results First Submit QC Date:
None
Results First Post Date:
2011-09-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-03
Last Update Post Date:
2015-04-23
Last Update Post Date Type:
ESTIMATED